share_log

Illumina | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Illumina | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Illumina | FWP：自由書寫募資說明書
美股SEC公告 ·  2024/09/04 15:45

Moomoo AI 已提取核心訊息

Illumina, Inc. has successfully issued $500 million in senior notes with a 4.650% interest rate, maturing on September 9, 2026. The notes, rated Baa3 by Moody's, BBB by S&P, and BBB by Fitch, all with a stable outlook, were traded on September 4, 2024, and are set to settle on September 9, 2024. Interest on these notes will be paid semi-annually starting March 9, 2025. The offering was managed by a syndicate led by J.P. Morgan Securities, Goldman Sachs & Co., BNP Paribas Securities Corp., and BofA Securities, with several co-managers also involved. The notes were priced to the public at 99.930% of their principal amount, with a yield to maturity slightly higher than the benchmark Treasury note. Illumina has provided a make-whole call and a change of control put at 101% of the principal plus accrued interest. The issuance is part of a registered offering, and the relevant documents have been filed with the SEC and are available on the EDGAR website or through the joint book-running managers.
Illumina, Inc. has successfully issued $500 million in senior notes with a 4.650% interest rate, maturing on September 9, 2026. The notes, rated Baa3 by Moody's, BBB by S&P, and BBB by Fitch, all with a stable outlook, were traded on September 4, 2024, and are set to settle on September 9, 2024. Interest on these notes will be paid semi-annually starting March 9, 2025. The offering was managed by a syndicate led by J.P. Morgan Securities, Goldman Sachs & Co., BNP Paribas Securities Corp., and BofA Securities, with several co-managers also involved. The notes were priced to the public at 99.930% of their principal amount, with a yield to maturity slightly higher than the benchmark Treasury note. Illumina has provided a make-whole call and a change of control put at 101% of the principal plus accrued interest. The issuance is part of a registered offering, and the relevant documents have been filed with the SEC and are available on the EDGAR website or through the joint book-running managers.
Illumina公司已成功發行了5億美元的優先票據，利率爲4.650%，於2026年9月9日到期。這些票據由穆迪評定爲Baa3級、標普評定爲BBb級、惠譽評定爲BBb級，均爲穩定展望，於2024年9月4日交易，定於2024年9月9日結算。這些票據的利息將從2025年3月9日開始每半年支付一次。這次發行由以摩根大通證券、高盛、法國巴黎銀行證券公司和美國銀行證券爲首的大型辛迪加管理，還有幾家共同經營管理公司參與。這些票據的發行價格爲其本金金額的99.930%，到期收益率略高於基準國債票據。illumina公司提供了完全清償看漲條款和變更控制看跌條款，金額爲本金加應計利息的101%。這次發行是註冊發行的一部分，相關文件已提交給美國證券交易委員會，並可通過EDGAR網站或共同的包銷經辦人獲取。
Illumina公司已成功發行了5億美元的優先票據，利率爲4.650%，於2026年9月9日到期。這些票據由穆迪評定爲Baa3級、標普評定爲BBb級、惠譽評定爲BBb級，均爲穩定展望，於2024年9月4日交易，定於2024年9月9日結算。這些票據的利息將從2025年3月9日開始每半年支付一次。這次發行由以摩根大通證券、高盛、法國巴黎銀行證券公司和美國銀行證券爲首的大型辛迪加管理，還有幾家共同經營管理公司參與。這些票據的發行價格爲其本金金額的99.930%，到期收益率略高於基準國債票據。illumina公司提供了完全清償看漲條款和變更控制看跌條款，金額爲本金加應計利息的101%。這次發行是註冊發行的一部分，相關文件已提交給美國證券交易委員會，並可通過EDGAR網站或共同的包銷經辦人獲取。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    GeneDx Holdings
    WGS
    -- 99.860
    ProPhase Labs
    PRPH
    -- 0.425
    Neuronetics
    STIM
    -- 4.710
    OncoCyte
    OCX
    -- 2.7600
    23andMe
    ME
    -- 2.745
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    美聯儲暫停降息，你如何調整持倉？
    美聯儲宣布基準利率維持在4.25%—4.50%不變，符合市場預期。你會如何配置資產？ 展开
    FOMC新聞發佈會，2025年1月29日